IGC Pharma, Inc. Common Stock (IGC)
0.2833
-0.0067 (-2.31%)
NYSE· Last Trade: May 28th, 1:23 PM EDT
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · August 28, 2025
Via Benzinga · August 27, 2025
Via Benzinga · July 22, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via Chartmill · July 11, 2025

Via Benzinga · September 3, 2024
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · July 10, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · July 10, 2025
Via Benzinga · July 10, 2025
Via Benzinga · July 10, 2025
Rebounding from a recent dip to $0.32, IGC Pharma's stock surged 69.4% to $0.62 on Wednesday, in after-hours trading.
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · July 9, 2025
U.S. futures rose on Monday after a record close on Friday. Futures of major benchmark indices were trading higher.
Via Benzinga · June 30, 2025
U.S. stock futures up, focus on PRGS, XCUR, QMCO earnings. VERO jumps 43.6% after stake increase, IGC reports positive results. Check out Cramer's oil pick. Photo: Shutterstock.
Via Benzinga · June 30, 2025
Via Benzinga · April 24, 2025

Via Benzinga · November 26, 2024

Via Benzinga · September 30, 2024

Via Benzinga · September 27, 2024

IGC stock results show that IGC Pharma beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via InvestorPlace · August 12, 2024

Via Benzinga · August 9, 2024

Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
Via InvestorPlace · June 25, 2024

IGC stock results show that IGC Pharma met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024.
Via InvestorPlace · June 24, 2024

Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks
Via Benzinga · June 13, 2024

Via Benzinga · June 11, 2024